20 critical questions: Helping you optimize reference standards for your biopharmaceutical across its development life cycle

This white paper explores challenges in understanding, identifying and managing reference standards for biopharmaceuticals. Their characterization is more nuanced than is the case for standards for small molecules. Their biological nature also makes them less stable: appropriate storage conditions and replacement strategies become all the more important.